Effect of aging and human immunodeficiency virus infection on cognitive abilities

Journal of the American Geriatrics Society

Volumn 60, Issue 11, 2012, Pages 2048-2055

  Ciccarelli, Nicoletta ^a   Fabbiani, Massimiliano ^a   Baldonero, Eleonora ^a   Fanti, Iuri ^a   Cauda, Roberto ^a   Giambenedetto, Simona Di ^a   Silveri, Maria Caterina ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

aging; antiretroviral therapy; human immunodeficiency virus (HIV); neuropsychological examination

Indexed keywords

ADULT; AGE; AGED; AGING; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; REACTION TIME; TASK PERFORMANCE;

ADULT; AGE FACTORS; AGED; AGING; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 84869108635     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2012.04213.x     Document Type: Article

References (50)

1. Brew BJ,. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004; 18 (Suppl 1): S75-S78.
2. Deeks SG,. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009; 17: 118-123.
3. Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: The Hawaii Aging with HIV-1 Cohort. Neurology 2004; 63: 822-827.
4. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001; 56: 257-260.
5. Mc Arthur JC,. HIV dementia: An evolving disease. J Neuroimmunol 2004; 157: 3-10.
6. Heaton RK, Clifford DB, Franklin DR, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75: 2087-2096.
7. Cysique LA, Brew BJ,. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: A review. Neuropsychol Rev 2009; 19: 169-185.
8. Ciccarelli N, Fabbiani M, Di Giambenedetto S, et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology 2011; 76: 1403-1409.
9. Liner J, Meeker RB, Robertson K,. CNS Toxicity of Antiretroviral Drugs, [abstract 435]. Presented at the 17th Conference on Retrovirus and Opportunistic Infections. San Francisco 2010. Available at http://www.retroconference.org/ 2010/Abstracts/39283.htm Accessed February 23, 2010.
10. Becker JT, Lopez OL, Dew MA, et al. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 2004; 18 (Suppl 1): S11-S18.
11. Brew B, Crowe SM, Landay A, et al. Neurodegeneration and aging in the HAART era. J Neuroimmune Pharmacol 2009; 4: 163-174.
12. Fabbiani M, Ciccarelli N, Tana M, et al. Cardiovascular risk factors and carotid intima-media thickness are associated to lower cognitive performance in HIV-infected patients. HIV Med 2012, doi: 10.1111/j.1468-1293.2012.01044.x.
13. Sacktor N, Skolasky R, Selnes OA, et al. Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol 2007; 13: 203-209.
14. Connor MD, Lammie GA, Bell JE, et al. Cerebral infarction in adult AIDS patients: Observations from the Edinburgh HIV Autopsy Cohort. Stroke 2000; 31: 2117-2126.
15. Hardy DJ, Vance DE,. The neuropsychology of HIV/AIDS in older adults. Neuropsychol Rev 2009; 19: 263-272.
16. Magalhães MG, Greenberg B, Hansen H, et al. Comorbidities in older patients with HIV: A retrospective study. J Am Dent Assoc 2007; 138: 1468-1475.
17. Ernst T, Chang L,. Effect of aging on brain metabolism in antiretroviral-naive HIV patients. AIDS 2004; 18 (Suppl 1): S61-S67.
18. Ettenhofer ML, Hinkin CH, Castellon SA, et al. Aging, neurocognition, and medication adherence in HIV infection. Am J Geriatr Psychiatry 2009; 17: 281-290.
19. Xu J, Ikezu T,. The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: A foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol 2009; 4: 200-212.
20. Scott JC, Woods SP, Carey CL, et al. Neurocognitive consequences of HIV infection in older adults: An evaluation of the "cortical" hypothesis. AIDS Behav 2011; 15: 1187-1196.
21. Alisky JM,. The coming problem of HIV-associated Alzheimer's disease. Med Hypotheses 2007; 69: 1140-1143.
22. Achim CL, Adame A, Dumaop W, et al. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol 2009; 4: 190-199.
23. Brew BJ, Pemberton L, Blennow K, et al. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 2005; 65: 1490-1492.
24. Esiri MM, Biddolph SC, Morris CS,. Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 1998; 65: 29-33.
25. Gelman BB, Schuenke K,. Brain aging in acquired immunodeficiency syndrome: Increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. J Neurovirol 2004; 10: 98-108.
26. Green DA, Masliah E, Vinters HV, et al. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 2005; 19: 407-411.
27. Foldi NS, Brickman AM, Schaefer LA, et al. Distinct serial position profiles and neuropsychological measures differentiate late life depression from normal aging and Alzheimer's disease. Psychiatry Res 2003; 120: 71-84.
28. Kirk JB, Goetz MB,. Human immunodeficiency virus in an aging population, a complication of success. J Am Geriatr Soc 2009; 57: 2129-2138.
29. Cysique LA, Maruff P, Bain MP, et al. HIV and age do not substantially interact in HIV-associated neurocognitive impairment. J Neuropsychiatry Clin Neurosci 2011; 23: 83-89.
30. Valcour V, Paul R, Neuhaus J, et al. The effects of age and HIV on neuropsychological performance. J Int Neuropsychol Soc 2011; 17: 190-195.
31. Morgan EE, Woods SP, Delano-Wood L, et al. HIV Neurobehavioral Research Program (HNRP) Group. Intraindividual variability in HIV infection: Evidence for greater neurocognitive dispersion in older HIV seropositive adults. Neuropsychology 2011; 25: 645-654.
32. Sacktor N, Skolasky RL, Cox C, et al. Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: Impact of age and serostatus. J Neurovirol 2010; 16: 335-341.
33. Letendre S, FitzSimons C, Ellis R,. Correlates of CSF Viral Loads in 1221 Volunteers of the CHARTER Cohort, [abstract 172]. Presented at the 17th Conference on Retrovirus and Opportunistic Infections; San Francisco 2010 [on-line]. Available at http://www.retroconference.org/2010/Abstracts/38339.htm. Accessed February 23, 2010.
34. Carlesimo GA, Caltagirone C, Gainotti G, et al. The Mental Deterioration Battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of Mental Deterioration Battery. Eur Neurol 1996; 36: 378-384.
35. Caffarra P, Vezzadini G, Dieci F, et al. Rey-Osterreth complex figure: Normative values in an Italian population sample. Neurol Sci 2002; 22: 443-447.
36. Orsini A, Grossi D, Capitani E, et al. Verbal and spatial immediate memory span: Normative data from 1355 adults and 1112 children. Ital J Neurol Sci 1987; 8: 539-548.
37. Caffarra P, Vezzadini G, Dieci F, et al. Una versione abbreviata del test di Stroop: Dati normativi nella popolazione italiana. Riv Neurol 2002; 12: 4.
38. Giovagnoli AR, Del Pesce M, Mascheroni S, et al. Trail making test: Normative values from 287 normal adult controls. Ital J Neurol Sci 1996; 17: 305-309.
39. Jenner C, Reali G, Puopolo M, et al. Can cognitive and behavioural disorders differentiate frontal variant-frontotemporal dementia from Alzheimer's disease at early stages? Behav Neurol 2006; 17: 89-95.
40. Marra C, Gainotti G, Scaricamazza E, et al. The Multiple Features Target Cancellation (MFTC): An attentional visual conjunction search test. Normative values for the Italian population. Neurol Sci 2012; doi: 10.1007/s10072-012- 0975-3.
41. Orsini A, Laicardi C,. WAIS-R. Contributo alla taratura italiana. Florence, Italy: Giunti OS, 1997.
42. Lovibond SH, Lovibond PF,. Manual for depression anxiety stress scales, 2nd Ed. Sydney, Australia: Psychology Foundation, 1995.
43. Ogunrin AO, Odiase FE, Ogunniyi A,. Reaction time in patients with HIV/AIDS and correlation with CD4 count: A case-control study. Trans R Soc Trop Med Hyg 2007; 101: 517-522.
44. Van Gorp WG, Miller EN, Satz P, et al. Neuropsychological performance in HIV-1 immunocompromised patients: A preliminary report. J Clin Exp Neuropsychol 1989; 11: 763-773.
45. Van Gorp WG, Miller EN, Marcotte TD, et al. The relationship between age and cognitive impairment in HIV-1 infection: Findings from the Multicenter AIDS Cohort Study and a clinical cohort. Neurology 1994; 44: 929-935.
46. Sánchez Rodríguez JL, Rodríguez Alvarez M,. Normal aging and AIDS. Arch Gerontol Geriatr 2003; 36: 57-65.
47. Salthouse TA,. The processing-speed theory of adult age differences in cognition. Psychol Rev 1996; 2: 404-410.
48. Angel L, Fay S, Bouazzaoui B, et al. Protective role of educational level on episodic memory aging: An event-related potential study. Brain Cogn 2010; 74: 312-323.
49. Stern RA, Silva SG, Chaisson N, et al. Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Arch Neurol 1996; 53: 148-153.
50. Ellis RJ, Badiee J, Vaida F, et al. Nadir CD4 is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 2011; 25: 1747-1751.